Hydroxocobalamin Injection Shortage: FDA Update
Hydroxocobalamin Injection is currently in shortage, with the only manufacturer reporting it as unavailable until June 2026, affecting patients who depend on this medication.
What's in Shortage
The generic drug Hydroxocobalamin Injection, also known by the brand name HYDROXOCOBALAMIN, is currently in shortage. It is an injection dosage form, and its status is listed as current. The therapeutic category is 'Other'. This shortage was first posted on 11/04/2024 and last updated on 04/01/2026.
Which Manufacturers Are Affected
Teva Pharmaceuticals USA, Inc. is the affected manufacturer, with the drug unavailable. Estimated recovery is June 2026. The presentation is Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30). For inquiries, their contact information is 800-545-8800.
Why There's a Shortage
The reason for the shortage is listed as 'Other'. No additional details were provided.
What Patients Should Do
Patients who rely on this medication should talk to their pharmacist or healthcare provider to discuss the shortage and explore options. They can also contact the manufacturer for more information. Please remember that patients should always consult their healthcare provider for any guidance on their treatment, as this article does not provide medical advice.
Source
This information is attributed to the FDA Drug Shortage Database.
Source: FDA Official Notice